Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep493 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Bronze diabetes – a rare secondary cause of diabetes

Souteiro Pedro , Neves Joao Sergio , Oliveira Sofia Castro , Belo Sandra , Neves Celestino , Freitas Paula , Carvalho Davide

Introduction: Secondary causes of diabetes refer to a category in which diabetes is associated with other diseases. They are thought to constitute less than 2% of the total cases of diabetes.Case report: A 56 year-old caucasian man, with no relevant medical history, presented to the Emergency Department with fatigue, polyuria, polydipsia, polyphagia and involuntary weight loss (6 kg in two weeks). He was hemodynamically stable and exhibited a glycaemia o...

ea0049ep1081 | Pituitary - Clinical | ECE2017

Hypopituitarism and central diabetes insipidus in an HIV patient – a late complication of cerebral toxoplasmosis and/or antiretrovirals?

Oliveira Sofia Castro , Souteiro Pedro , Neves Joao Sergio , Nogueira Claudia , Neves Celestino , Freitas Paula , Carvalho Davide

Introduction: The endocrine system is often affected in the course of HIV infection. However, hypopituitarism and diabetes insipidus are uncommon disorders in these patients and have been related to drugs, infections of the central nervous system and neoplastic infiltration, in extremely rare cases.Case report: We present a case of a 42-year-old man with HIV infection known since 2005, but undergoing antiretroviral therapy only since 2010 (emtricitabine/...

ea0041ep548 | Diabetes therapy | ECE2016

Intensive therapy with insulin pump in type 1 diabetes mellitus

Gouveia Ines , Neves Celestino , Oliveira Sofia , Neves Joao Sergio , Dias Claudia , Carvalho Davide

Background: Continuous subcutaneous insulin infusion (CSII), alongside multiple daily injections (MDI) are the most frequent therapeutic of type 1 Diabetes Mellitus (DM). We aimed to evaluate the effects of the transition from MDI to CSII in the treatment of type 1 DM.Patients and methods: This retrospective longitudinal study analysed patients that received treatment with CSII from 2006 to 2014. Our sample had 85 patients, 35 male (41.2%) and 50 female ...

ea0056p402 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Major adverse cardiovascular events and in-hospital outcomes in patients with diabetes

Neves Celestino , Sergio Neves Joao , Oliveira Sofia Castro , Pereira Miguel , Oliveira Ana , Carvalho Davide

Background: Diabetes is an important risk factor for major adverse cardiovascular events (MACE). Although the increased risk for MACE is well known, the impact on the in-hospital outcomes remains incompletely understood. Our aim was to evaluate the interrelation between diabetes and MACE in a central hospital in the North of Portugal between 2009 and 2015.Methods: We evaluated retrospectively the hospitalizations due to MACE including stroke or transient...

ea0099p380 | Thyroid | ECE2024

Interrelationships between thyroid function, autoimmunity, low-grade inflammation, lipid profile and insulin resistance in graves’ disease

Neves Celestino , Sergio Neves Joao , Miguel Pereira Luis , Sokhatska Oksana , Queiros Joana , Luis Delgado Jose

Aim: The aim of this study was to evaluate the association between thyroid function in Graves’ disease (GD) with high-sensitivity C-reactive protein (hs-CRP), lipid profile, homocysteine, folate, vitamin B12 and insulin resistance.Methods: We performed a cross-sectional of 104 patients with recently diagnosed GD. All participants were in the first cycle of treatment with methimazole. We collected demographic information, body mass indexes (BMI), lab...

ea0049gp26 | Adrenal 3 | ECE2017

Metformin reduces viability and proliferation of pheochromocytoma cells in vitro

Meireles Cinthia , Neves Francisco , Simeoni Luiz , Lofrano-Porto Adriana

Background: Pheochromocytomas (PHEO) are rare neuroendocrine tumors derived from chromaffin cells of the adrenal medulla. Catecholamins’ secretion is associated with a high risk of cardiovascular complications. Malignancy is rare, but still demands effective treatment. Metformin has been shown to have antiproliferative properties in several cancer cell lines, possibly related to its ability to inhibit cell proliferation pathways. Accordingly, we aimed to evaluate the effe...

ea0041ep426 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Diagnostic and therapeutic stratagies in maturity onset diabetes of the young

Oliveira Sofia , Neves Celestino , Esteves Cesar , Pignatelli Duarte , Carvalho Davide

Background: Maturity onset diabetes of the young (MODY) has an estimated prevalence of 1–5% in the diabetic population, but misdiagnosis as type 1 or type 2 diabetes is common. It comprises a heterogeneous group of monogenic diseases characterized by primary dysfunction of β cell, young onset, autosomal dominant inheritance, without autoimmunity and without ketosis. Early diagnosis remains a challenge with important future implications, since it allows treatment opti...

ea0032p1067 | Thyroid (non-cancer) | ECE2013

Marine–lenhart syndrome

Esteves Cesar , Neves Celestino , Vieira Tiago , Pereira Jorge , Carvalho Davide

Introduction: The Marine–Lenhart syndrome is a rare cause of hyperthyroidism that is associated with the simultaneous or sequential presence of characteristics related to Graves’ disease and toxic nodular or multinodular goiter. It’s validity as a disease is controversial and some authors believe that these are cases of hyperthyroidism where both etiologies coexist. The presence of hyperfunctioning nodules in Graves’ disease patients ranges between 0.8 and ...

ea0029p693 | Diabetes | ICEECE2012

Variations in insulin daily dose and weight with continuous subcutaneous insulin infusion therapy

Belo S. , Esteves C. , Pereira M. , Neves C. , Carvalho D.

Introduction: Intensive diabetes type 1 management can be achieved either with multiple daily insulin injection therapy or with continuous subcutaneous insulin infusion (CSII). The former is becoming increasingly popular do to its positive effects on glycemic control.Objectives: Evaluate the evolution of total daily insulin dose (TDID) and weight on patients with CSII.Methods: Patients with CSII of our department were included. Dat...

ea0029p1778 | Thyroid cancer | ICEECE2012

Thyroid papillary carcinoma, 30 years of experience

Costa Leite B. , Neves S. , Moreira da Costa A. , Canha A.

Papillary carcinoma is the most common histological type of thyroid cancer. The optimal treatment remains controversial, particularly with regard to the papillary microcarcinoma (≤ 10 mm).The aim of this study is the characterization of patients with this condition undergoing surgery in our hospital over a period of 30 years, evaluating treatment outcomes.Between January 1, 1980 and December 31, 2010, a total of 564 patients ...